Table 3.
Comparison of Fluorescein Clearance Test (FCT) Between FCT at Baseline and FCT at 1 Month After BTX-A Injection in Homolateral and Contralateral Eye
Baseline (n= 30) | 1-Month Follow-Up (n=27) | P | |
---|---|---|---|
Homolateral eye | |||
Basal tear secretion (mm), median (Q1,Q3)† | 3.5 (2,6) | 5 (1,9) | 0.424 |
Delayed tear clearance (%)# | 20 out of 26 (76.92%) | 24 out of 26 (92.31%) | 0.103 |
Reflex tear (%)# | 17 out of 26 (65.38%) | 11 out of 26 (42.31%) | 0.083 |
Contralateral eye | |||
Basal tear secretion (mm), median (Q1,Q3)† | 2.75 (1,7) | 3 (1,6) | 0.308 |
Delayed tear clearance (%)# | 16 out of 26 (61.54%) | 21 out of 26 (80.77%) | 0.059 |
Reflex tear (%)# | 16 out of 26 (61.54%) | 17 out of 26 (65.38%) | 0.706 |
Notes: †P value by the Wilcoxon signed-rank test; #P value by McNemar’s test.